A randomised, double-blind, placebo controlled trial to evaluate the safety and efficacy of parecoxib and valdecoxib after noncardiac surgery

Trial Profile

A randomised, double-blind, placebo controlled trial to evaluate the safety and efficacy of parecoxib and valdecoxib after noncardiac surgery

Not stated
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Parecoxib (Primary) ; Parecoxib (Primary) ; Valdecoxib
  • Indications Pain; Postoperative pain
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Jun 2017 Results of subgroup analysis assessing analgesic and opioid-Sparing effects published in the Pain and Therapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top